168 related articles for article (PubMed ID: 35135186)
1. Tumor-induced Osteomalacia in a Boy with Maxillary Ossifying Fibroma.
Thi HN; Manh CP; Tuan LT; Le Thi LA; Thanh NN; Vilaiyuk S
J Clin Res Pediatr Endocrinol; 2023 Nov; 15(4):421-425. PubMed ID: 35135186
[TBL] [Abstract][Full Text] [Related]
2. Tumor-induced osteomalacia associated with a maxillofacial tumor producing fibroblast growth factor 23: report of a case and review of the literature.
Mori Y; Ogasawara T; Motoi T; Shimizu Y; Chikazu D; Tamura K; Fukumoto S; Takato T
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Mar; 109(3):e57-63. PubMed ID: 20219587
[TBL] [Abstract][Full Text] [Related]
3. A rare case of multiple phosphaturic mesenchymal tumors along a tendon sheath inducing osteomalacia.
Arai R; Onodera T; Terkawi MA; Mitsuhashi T; Kondo E; Iwasaki N
BMC Musculoskelet Disord; 2017 Feb; 18(1):79. PubMed ID: 28193220
[TBL] [Abstract][Full Text] [Related]
4. Hypophosphatemia related to a neuro-endocrine tumor of the pancreas: A case report.
Pickering ME; Bouvier D; Puravet A; Soubrier M; Sapin V; Oris C
Clin Biochem; 2022 Jun; 104():62-65. PubMed ID: 35337828
[TBL] [Abstract][Full Text] [Related]
5. Tumor-induced Osteomalacia in a 3-Year-Old With Unresectable Central Giant Cell Lesions.
Crossen SS; Zambrano E; Newman B; Bernstein JA; Messner AH; Bachrach LK; Twist CJ
J Pediatr Hematol Oncol; 2017 Jan; 39(1):e21-e24. PubMed ID: 27820122
[TBL] [Abstract][Full Text] [Related]
6. Tumor-induced osteomalacia with elevated fibroblast growth factor 23: a case of phosphaturic mesenchymal tumor mixed with connective tissue variants and review of the literature.
Hu FK; Yuan F; Jiang CY; Lv DW; Mao BB; Zhang Q; Yuan ZQ; Wang Y
Chin J Cancer; 2011 Nov; 30(11):794-804. PubMed ID: 22035861
[TBL] [Abstract][Full Text] [Related]
7. Successful treatment of tumor-induced osteomalacia due to an intracranial tumor by fractionated stereotactic radiotherapy.
Tarasova VD; Trepp-Carrasco AG; Thompson R; Recker RR; Chong WH; Collins MT; Armas LA
J Clin Endocrinol Metab; 2013 Nov; 98(11):4267-72. PubMed ID: 24014621
[TBL] [Abstract][Full Text] [Related]
8. Tumor-induced hypophosphatemic osteomalacia diagnosed by the combinatory procedures of magnetic resonance imaging and venous sampling for FGF23.
Nasu T; Kurisu S; Matsuno S; Tatsumi K; Kakimoto T; Kobayashi M; Nakano Y; Wakasaki H; Furuta H; Nishi M; Sasaki H; Suzuki H; Ito N; Fukumoto S; Nanjo K
Intern Med; 2008; 47(10):957-61. PubMed ID: 18480582
[TBL] [Abstract][Full Text] [Related]
9. Long-term use of burosumab for the treatment of tumor-induced osteomalacia.
Crotti C; Zucchi F; Alfieri C; Caporali R; Varenna M
Osteoporos Int; 2023 Jan; 34(1):201-206. PubMed ID: 35925260
[TBL] [Abstract][Full Text] [Related]
10. Tumor-induced osteomalacia associated with lesions in the oral and maxillofacial region: report of two cases.
Kim YG; Choi YS; Lee SC; Ryu DM
J Oral Maxillofac Surg; 1996 Nov; 54(11):1352-7. PubMed ID: 8941189
[No Abstract] [Full Text] [Related]
11. Tumor-induced osteomalacia - a mystery illness beyond aches, pains, and depression.
Ni HJ; Clifton-Bligh R; Brzozowska MM
Endocr Regul; 2021 Sep; 55(3):163-168. PubMed ID: 34523297
[No Abstract] [Full Text] [Related]
12. Tumor induced osteomalacia from a peripheral mesenchymal tumour of the foot.
Strydom A; Greeff W; Ferrao PNF; Saragas NP
Foot (Edinb); 2023 May; 55():101979. PubMed ID: 36871520
[TBL] [Abstract][Full Text] [Related]
13. Challenges in the management of tumor-induced osteomalacia (TIO).
Brandi ML; Clunie GPR; Houillier P; Jan de Beur SM; Minisola S; Oheim R; Seefried L
Bone; 2021 Nov; 152():116064. PubMed ID: 34147708
[TBL] [Abstract][Full Text] [Related]
14. Prolonged Hypophosphatemia and Intensive Care After Curative Surgery of Tumor Induced Osteomalacia: A Case Report.
Ryhänen EM; Schalin-Jäntti C; Matikainen N
Front Endocrinol (Lausanne); 2021; 12():686135. PubMed ID: 34149623
[TBL] [Abstract][Full Text] [Related]
15. Tumour-induced osteomalacia.
Minisola S; Peacock M; Fukumoto S; Cipriani C; Pepe J; Tella SH; Collins MT
Nat Rev Dis Primers; 2017 Jul; 3():17044. PubMed ID: 28703220
[TBL] [Abstract][Full Text] [Related]
16. Ameloblastic Fibroodontoma of Mandible Causing Tumor Induced Osteomalacia: A Case Report with Review of 88 Phosphaturic Oral Neoplasms.
Mishra D; Kaur H; Bhalla AS; Manchanda S; Sasikumar J; Agarwal B; Roychoudhury A
Head Neck Pathol; 2021 Sep; 15(3):975-988. PubMed ID: 33394371
[TBL] [Abstract][Full Text] [Related]
17. Tumor-induced osteomalacia combined with increased bone resorption postoperatively: A case report.
Shi L; Tang M; Duan S; Deng F; Zhang Y; Yang J; Hu J
Medicine (Baltimore); 2023 Jul; 102(27):e34217. PubMed ID: 37417620
[TBL] [Abstract][Full Text] [Related]
18. Sensitivity of fibroblast growth factor 23 measurements in tumor-induced osteomalacia.
Imel EA; Peacock M; Pitukcheewanont P; Heller HJ; Ward LM; Shulman D; Kassem M; Rackoff P; Zimering M; Dalkin A; Drobny E; Colussi G; Shaker JL; Hoogendoorn EH; Hui SL; Econs MJ
J Clin Endocrinol Metab; 2006 Jun; 91(6):2055-61. PubMed ID: 16551733
[TBL] [Abstract][Full Text] [Related]
19. Bilateral subtrochanteric fractures in tumour-induced osteomalacia caused by a nasal haemangiopericytoma.
Burnand H; Samuels A; Hagan I; Sawant N; Mutimer J
Hip Int; 2012; 22(2):227-9. PubMed ID: 22547377
[TBL] [Abstract][Full Text] [Related]
20. A case of hyperparathyroidism secondary to tumor-induced osteomalacia.
Yang Y; Jin P; Zhang S; Chen K; He H; Mo Z; Yuan J
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Dec; 48(12):1937-1944. PubMed ID: 38448388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
